{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:15:32Z","timestamp":1791828932512,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1124\/dmd.124.001824","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T14:15:15Z","timestamp":1729520115000},"page":"100007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Absolute membrane protein abundance of P-glycoprotein, breast cancer resistance protein, and multidrug resistance proteins in term human placenta tissue and commonly used cell systems: Application in physiologically based pharmacokinetic modeling of placental drug disposition"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1497-3140","authenticated-orcid":false,"given":"Zubida M.","family":"Al-Majdoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolien J.M.","family":"Freriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Colbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Koenderink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Abduljalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2595-5626","authenticated-orcid":false,"given":"Brahim","family":"Achour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5424-0291","authenticated-orcid":false,"given":"Jill","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2599-7540","authenticated-orcid":false,"given":"Rick","family":"Greupink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3917-844X","authenticated-orcid":false,"given":"Amin","family":"Rostami-Hodjegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.124.001824_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10928-020-09698-w","article-title":"Drug dosing during pregnancy-opportunities for physiologically based pharmacokinetic models","volume":"47","author":"Abduljalil","year":"2020","journal-title":"J\u00a0Pharmacokinet Pharmacodyn"},{"key":"10.1124\/dmd.124.001824_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/11597440-000000000-00000","article-title":"Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling","volume":"51","author":"Abduljalil","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.124.001824_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s40262-021-01103-0","article-title":"Prediction of maternal and fetal acyclovir, emtricitabine, lamivudine, and metformin concentrations during pregnancy using a physiologically based pharmacokinetic modeling approach","volume":"61","author":"Abduljalil","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.124.001824_bib4","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/cpt.2732","article-title":"Is liquid biopsy only restricted to diagnostics or can it go beyond the confines of genotyping and phenotyping for quantitative pharmacology?","volume":"112","author":"Achour","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001824_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2016.08.002","article-title":"Placental control of drug delivery","volume":"116","author":"Al-Enazy","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.124.001824_bib6","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1021\/acs.molpharmaceut.8b01189","article-title":"Proteomic quantification of human blood-brain barrier SLC and ABC transporters in healthy individuals and dementia patients","volume":"16","author":"Al-Majdoub","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.124.001824_bib7","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/cpt.2396","article-title":"Quantitative proteomic map of enzymes and transporters in the human kidney: stepping closer to mechanistic kidney models to define local kinetics","volume":"110","author":"Al-Majdoub","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001824_bib8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1124\/dmd.120.000067","article-title":"Gestational age-dependent abundance of human placental transporters as determined by quantitative targeted proteomics","volume":"48","author":"Anoshchenko","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001824_bib9","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.whi.2012.10.003","article-title":"Enrolling pregnant women: issues in clinical research","volume":"23","author":"Blehar","year":"2013","journal-title":"Womens Health Issues"},{"key":"10.1124\/dmd.124.001824_bib10","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1530\/REP-20-0354","article-title":"Animal models of human pregnancy and placentation: alternatives to the mouse","volume":"160","author":"Carter","year":"2020","journal-title":"Reproduction"},{"key":"10.1124\/dmd.124.001824_bib11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/toxics10050232","article-title":"IVIVE: facilitating the use of in\u00a0vitro toxicity data in risk assessment and decision making","volume":"10","author":"Chang","year":"2022","journal-title":"Toxics"},{"key":"10.1124\/dmd.124.001824_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100186","article-title":"Subcellular transcriptomics and proteomics: a comparative methods review","volume":"21","author":"Christopher","year":"2022","journal-title":"Mol Cell Proteomics"},{"issue":"Suppl 1","key":"10.1124\/dmd.124.001824_bib13","first-page":"S70","article-title":"Drug transporters expressed in the human placenta and models for studying maternal-fetal drug transfer","volume":"59","author":"Dallmann","year":"2019","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1124\/dmd.124.001824_bib14","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1021\/acs.molpharmaceut.1c00462","article-title":"Non-uniformity of changes in drug-metabolizing enzymes and transporters in liver cirrhosis: implications for drug dosage adjustment","volume":"18","author":"El-Khateeb","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.124.001824_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00204-020-02925-w","article-title":"Toxicity of anticancer drugs in human placental tissue explants and trophoblast cell lines","volume":"95","author":"Eliesen","year":"2021","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.124.001824_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.placenta.2004.05.013","article-title":"P-glycoprotein expression of the human placenta during pregnancy","volume":"26","author":"Gil","year":"2005","journal-title":"Placenta"},{"key":"10.1124\/dmd.124.001824_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.837694","article-title":"Gestational age variation in human placental drug transporters","volume":"13","author":"Goetzl","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1124\/dmd.124.001824_bib18","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.3390\/pharmaceutics15112624","article-title":"A\u00a0literature review of changes in phase II drug-metabolizing enzyme and drug transporter expression during pregnancy","volume":"15","author":"Gong","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1124\/dmd.124.001824_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-0035-1570031","article-title":"Animal models to study placental development and function throughout normal and dysfunctional human pregnancy","volume":"34","author":"Grigsby","year":"2016","journal-title":"Semin Reprod Med"},{"key":"10.1124\/dmd.124.001824_bib20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/17425255.2018.1499726","article-title":"An update on expression and function of P-gp\/ABCB1 and BCRP\/ABCG2 in the placenta and fetus","volume":"14","author":"Han","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.124.001824_bib21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1124\/dmd.115.067777","article-title":"In\u00a0vitro-in\u00a0vivo extrapolation scaling factors for intestinal p-glycoprotein and breast cancer resistance protein: part II. The impact of cross-laboratory variations of intestinal transporter relative expression factors on predicted drug disposition","volume":"44","author":"Harwood","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001824_bib22","series-title":"Transporters in Drug Development","first-page":"475","article-title":"Application of physiologically based pharmacokinetic and pharmacodynamic (PBPK\/PD) modeling comprising transporters: delineating the role of various factors in drug disposition and toxicity","author":"Harwood","year":"2022"},{"key":"10.1124\/dmd.124.001824_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.placenta.2012.01.008","article-title":"Placental drug transporters and their role in fetal protection","volume":"33","author":"Iqbal","year":"2012","journal-title":"Placenta"},{"key":"10.1124\/dmd.124.001824_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120867","article-title":"Expression of CYP450 enzymes in human fetal membranes and its implications in xenobiotic metabolism during pregnancy","volume":"307","author":"Kammala","year":"2022","journal-title":"Life Sci"},{"key":"10.1124\/dmd.124.001824_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/psp4.12274","article-title":"Drug dosing in pregnant women: challenges and opportunities in using physiologically based pharmacokinetic modeling and simulations","volume":"7","author":"Ke","year":"2018","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1124\/dmd.124.001824_bib26","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00204-013-1074-9","article-title":"Assessment of an in\u00a0vitro transport model using BeWo b30 cells to predict placental transfer of compounds","volume":"87","author":"Li","year":"2013","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.124.001824_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004365","article-title":"Medication use in pregnancy: a cross-sectional, multinational web-based study","volume":"4","author":"Lupattelli","year":"2014","journal-title":"BMJ Open"},{"key":"10.1124\/dmd.124.001824_bib28","doi-asserted-by":"crossref","first-page":"R963","DOI":"10.1152\/ajpregu.00173.2005","article-title":"P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages","volume":"289","author":"Mathias","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/dmd.124.001824_bib29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1124\/dmd.105.007591","article-title":"Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP)","volume":"34","author":"Meyer zu Schwabedissen","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001824_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jprot.2018.12.012","article-title":"Proteomics turns functional","volume":"198","author":"Monti","year":"2019","journal-title":"J\u00a0Proteomics"},{"key":"10.1124\/dmd.124.001824_bib31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/molehr\/gaz061","article-title":"Transcriptomic profiling of trophoblast fusion using BeWo and JEG-3 cell lines","volume":"25","author":"Msheik","year":"2019","journal-title":"Mol Hum Reprod"},{"key":"10.1124\/dmd.124.001824_bib32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2133\/dmpk.20.452","article-title":"Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies","volume":"20","author":"Nishimura","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.124.001824_bib33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/cpt.1537","article-title":"Toward a consensus on applying quantitative liquid chromatography-tandem mass spectrometry proteomics in translational pharmacology research: a white paper","volume":"106","author":"Prasad","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001824_bib34","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jps.20502","article-title":"Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions","volume":"95","author":"Rodgers","year":"2006","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1124\/dmd.124.001824_bib35","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1021\/pr400279u","article-title":"Alternative fusion protein strategies to express recalcitrant QconCAT proteins for quantitative proteomics of human drug metabolizing enzymes and transporters","volume":"12","author":"Russell","year":"2013","journal-title":"J\u00a0Proteome Res"},{"key":"10.1124\/dmd.124.001824_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.placenta.2022.05.003","article-title":"Ex\u00a0vivo dual perfusion of an isolated human placenta cotyledon: towards protocol standardization and improved inter-centre comparability","volume":"126","author":"Schneider","year":"2022","journal-title":"Placenta"},{"key":"10.1124\/dmd.124.001824_bib37","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/1061186X.2012.716847","article-title":"Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure","volume":"20","author":"Staud","year":"2012","journal-title":"J\u00a0Drug Target"},{"key":"10.1124\/dmd.124.001824_bib38","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.placenta.2005.05.007","article-title":"Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation","volume":"27","author":"Sun","year":"2006","journal-title":"Placenta"},{"key":"10.1124\/dmd.124.001824_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2022.104572","article-title":"A\u00a0family of QconCATs (quantification concatemers) for the quantification of human pharmacological target proteins","volume":"261","author":"Vasilogianni","year":"2022","journal-title":"J\u00a0Proteomics"},{"key":"10.1124\/dmd.124.001824_bib40","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1021\/mp200617z","article-title":"Exploiting transport activity of p-glycoprotein at the blood-brain barrier for the development of peripheral cannabinoid type 1 receptor antagonists","volume":"9","author":"Wittgen","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.124.001824_bib41","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/dmd.117.075192","article-title":"Development of a novel maternal-fetal physiologically based pharmacokinetic model I: insights into factors that determine fetal drug exposure through simulations and sensitivity analyses","volume":"45","author":"Zhang","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001824_bib42","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1124\/dmd.116.073957","article-title":"Development of a novel maternal-fetal physiologically based pharmacokinetic model II: verification of the model for passive placental permeability drugs","volume":"45","author":"Zhang","year":"2017","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624148477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624148477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.124.001824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:37:16Z","timestamp":1761194236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624148477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0090955624148477"],"URL":"https:\/\/doi.org\/10.1124\/dmd.124.001824","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Absolute membrane protein abundance of P-glycoprotein, breast cancer resistance protein, and multidrug resistance proteins in term human placenta tissue and commonly used cell systems: Application in physiologically based pharmacokinetic modeling of placental drug disposition","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.124.001824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100007"}}